Chromoendoscopy for inflammatory bowel disease Jan. 09, 2017 Overview Show transcript Overview Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleExamining the efficacy of recombinant zoster vaccination in patients with IBDArticleExamining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD VID-20480174 Medical Professionals Chromoendoscopy for inflammatory bowel disease